Greif SVP, Chief Commercial Officer Timothy Bergwall sells 2,000 common shares worth $166,289.60
Reuters2026/09/14 22:03- Greif SVP, Chief Commercial Officer Timothy Bergwall sold 2,000 Class A common shares on Sept. 10, 2026.
- Sale price USD 83.14 per share.
- Direct holdings fell to 53,831 shares; indirect 401(k) plan holdings listed at 1,324 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations